Robl; Jeffrey A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Robl; Jeffrey A..The latest application filed is for "cyclopropanecarboxylic acid gpr120 modulators".

Company Profile

3.58.42

Robl; Jeffrey A. - New Hope PA
Robl; Jeffrey A. - Newtown PA
- Newtown PA US
Robl; Jeffrey A. - Newton PA
Robl; Jeffrey A. - Holland PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cyclopropanecarboxylic acid GPR120 modulators Grant 9,938,222 - Shi , et al. April 10, 2	2018-04-10
Cyclopropanecarboxylic Acid Gpr120 Modulators App 20170253554 - Shi; Yan ; et al.	2017-09-07
Bicyclic nitrogen containing heteroaryl TGR5 receptor modulators Grant 9,062,028 - Robl , et al. June 23, 2	2015-06-23
Bicyclic heteroaryl compounds as GPR119 modulators Grant 8,940,716 - Ye , et al. January 27, 2	2015-01-27
Benzofuranyl analogues as GPR119 modulators Grant 8,729,084 - Ye , et al. May 20, 2	2014-05-20
Pyridone/hydroxypyridine 11-beta Hydroxysteroid Dehydrogenase Type I Inhibitors App 20140128365 - Robl; Jeffrey A. ; et al.	2014-05-08
Novel Bicyclic Nitrogen Containing Heteroaryl Tgr5 Receptor Modulators App 20140080788 - Robl; Jeffrey A. ; et al.	2014-03-20
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them Grant 8,618,115 - Washburn , et al. December 31, 2	2013-12-31
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them Grant 08618115 -	2013-12-31
Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists Grant 8,563,583 - Ahmad , et al. October 22, 2	2013-10-22
Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors Grant 8,546,394 - Li , et al. October 1, 2	2013-10-01
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors Grant 8,541,444 - Li , et al. September 24, 2	2013-09-24
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method Grant RE44,186 - Robl , et al. April 30, 2	2013-04-30
Benzofuranyl Analogues As Gpr119 Modulators App 20130059858 - Ye; Xiang-Yang ; et al.	2013-03-07
Bicyclic Heteroarly Analogues As Gpr119 Modulators App 20130053345 - Ye; Xiang-Yang ; et al.	2013-02-28
Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors Grant 8,318,941 - Robl , et al. November 27, 2	2012-11-27
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors Grant 8,148,396 - Li , et al. April 3, 2	2012-04-03
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors Grant 8,119,658 - Li , et al. February 21, 2	2012-02-21
Pyridone Analogs Useful As Melanin Concentrating Hormone Receptor-1 Antagonists App 20110319449 - Ahmad; Saleem ; et al.	2011-12-29
Triazolopyridine 11-beta Hydroxysteroid Dehydrogenase Type I Inhibitors App 20110288051 - Li; Jun ; et al.	2011-11-24
Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonists Grant 7,989,433 - Washburn , et al. August 2, 2	2011-08-02
Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors Grant 7,834,178 - Li , et al. November 16, 2	2010-11-16
Cyclic 11-beta Hydroxysteroid Dehydrogenase Type I Inhibitors App 20100204199 - Ye; Xiang-Yang ; et al.	2010-08-12
Fused Heterocyclic 11-beta-hydroxysteroid Dehydrogenase Type 1 Inhibitors App 20100144744 - Li; Jun ; et al.	2010-06-10
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors Grant 7,727,978 - Ye , et al. June 1, 2	2010-06-01
HMG-CoA reductase inhibitors Grant 7,659,281 - Stein , et al. February 9, 2	2010-02-09
Pyridone/hydroxypyridine 11-beta Hydroxysteroid Dehydrogenase Type I Inhibitors App 20100009960 - Robl; Jeffrey A. ; et al.	2010-01-14
Hydroxy Substituted Thieno Pyrimidinones As Melanin Concentrating Hormone Receptor-1 Antagonists App 20090298794 - Washburn; William N. ; et al.	2009-12-03
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors Grant 7,579,360 - Li , et al. August 25, 2	2009-08-25
Triazolopyridine 11-beta Hydroxysteroid Dehydrogenase Type I Inhibitors App 20090093516 - Li; Jun ; et al.	2009-04-09
Method for treating atherosclerosis employing an aP2 inhibitor and combination App 20090076033 - Robl; Jeffrey A. ; et al.	2009-03-19
Pyrazolyl inhibitors of 15-lipoxygenase Grant 7,432,271 - Ngu , et al. October 7, 2	2008-10-07
Cyclic 11-beta Hydroxysteroid Dehydrogenase Type I Inhibitors App 20080234249 - Ye; Xiang-Yang ; et al.	2008-09-25
Method for treating diabetes employing an aP2 inhibitor and combination Grant 7,390,824 - Robl , et al. June 24, 2	2008-06-24
HMG-CoA reductase inhibitors and method Grant 7,371,759 - Ahmad , et al. May 13, 2	2008-05-13
Method for treating atherosclerosis employing an aP2 inhibitor and combination Grant 7,358,254 - Robl , et al. April 15, 2	2008-04-15
Imidazolyl inhibitors of 15-lipoxygenase Grant 7,317,032 - Weinstein , et al. January 8, 2	2008-01-08
HMG-CoA reductase inhibitors App 20070249583 - Stein; Philip D. ; et al.	2007-10-25
Triazine 11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors App 20070207985 - Li; Jun ; et al.	2007-09-06
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors App 20060287357 - Li; James J. ; et al.	2006-12-21
Heterocyclic aromatic compounds useful as growth hormone secreagogues Grant 7,053,110 - Robl , et al. May 30, 2	2006-05-30
Bicyclic modulators of androgen receptor function Grant 6,992,102 - Hamann , et al. January 31, 2	2006-01-31
Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein Grant 6,984,645 - Magnin , et al. January 10, 2	2006-01-10
Heterocyclic aromatic compounds useful as growth hormone secretagogues Grant 6,969,727 - Robl , et al. November 29, 2	2005-11-29
Heterocyclic containing biphenyl aP2 inhibitors and method Grant 6,927,227 - Robl , et al. August 9, 2	2005-08-09
Pyridazinone inhibitors of fatty acid binding protein and method Grant 6,919,323 - Sulsky , et al. July 19, 2	2005-07-19
Heterocyclic aromatic compounds useful as growth hormone secretagogues Grant 6,908,938 - Robl , et al. June 21, 2	2005-06-21
HMG-CoA reductase inhibitors and method App 20050085497 - Ahmad, Saleem ; et al.	2005-04-21
Pyrazolyl inhibitors of 15- lipoxygenase App 20050070589 - Ngu, Khehyong ; et al.	2005-03-31
Imidazolyl inhibitors of 15-lipoxygenase App 20050070588 - Weinstein, David S. ; et al.	2005-03-31
Method for treating atherosclerosis employing an aP2 inhibitor and combination App 20040229807 - Robl, Jeffrey A. ; et al.	2004-11-18
HMG-CoA reductase inhibitors and method Grant 6,812,345 - Robl , et al. November 2, 2	2004-11-02
N-formyl hydroxylamine containing compounds useful as ACE inhibitors and/or NEP inhibitors Grant 6,777,550 - Robl August 17, 2	2004-08-17
HMG-CoA reductase inhibitors and method App 20040092573 - Robl, Jeffrey A. ; et al.	2004-05-13
Heterocyclic aromatic compounds useful as growth hormone secreagogues App 20040072881 - Robl, Jeffrey A. ; et al.	2004-04-15
Heterocyclic aromatic compounds useful as growth hormone secretagogues App 20040029935 - Robl, Jeffrey A. ; et al.	2004-02-12
HMG-CoA reductase inhibitors and method App 20040024216 - Robl, Jeffrey A. ; et al.	2004-02-05
Pyridone inhibitors of fatty acid binding protein and method Grant 6,670,380 - Sulsky , et al. December 30, 2	2003-12-30
Bicyclic modulators of androgen receptor function Grant 6,670,386 - Sun , et al. December 30, 2	2003-12-30
Heterocyclic aromatic compounds useful as growth hormone secretagogues Grant 6,660,760 - Robl , et al. December 9, 2	2003-12-09
Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein App 20030225091 - Magnin, David R. ; et al.	2003-12-04
Tetrahydropyrimidone inhibitors of fatty acid binding protein and method Grant 6,649,622 - Sulsky , et al. November 18, 2	2003-11-18
Heterocyclic containing biphenyl aP2 inhibitors and method App 20030199563 - Robl, Jeffrey A. ; et al.	2003-10-23
HMG-CoA reductase inhibitors and method Grant 6,627,636 - Robl September 30, 2	2003-09-30
HMG-CoA reductase inhibitors and method Grant 6,620,821 - Robl September 16, 2	2003-09-16
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method Grant 6,573,287 - Sulsky , et al. June 3, 2	2003-06-03
Heterocyclic containing biphenyl aP2 inhibitors and method Grant 6,548,529 - Robl , et al. April 15, 2	2003-04-15
Bicyclic modulators of androgen receptor function App 20030055094 - Sun, Chongqing ; et al.	2003-03-20
Pyrazinone inhibitors of fatty acid binding protein and method App 20030040516 - Sulsky, Richard ; et al.	2003-02-27
Hydroxamic Acid Containing Compounds Useful As Ace Inhibitors And / Or Nep Inhibitors App 20020193562 - Robl, Jeffrey A.	2002-12-19
2,1-Oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method App 20020183367 - Sulsky, Richard B. ; et al.	2002-12-05
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method Grant 6,472,414 - Biller , et al. October 29, 2	2002-10-29
HMG-CoA reductase inhibitors and method App 20020094977 - Robl, Jeffrey A. ; et al.	2002-07-18
Tetrahydropyrimidone inhibitors of fatty acid binding protein and method App 20020091078 - Sulsky, Richard ; et al.	2002-07-11
Pyridone inhibitors of fatty acid binding protein and method App 20020077340 - Sulsky, Richard ; et al.	2002-06-20
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method Grant 6,395,767 - Robl , et al. May 28, 2	2002-05-28
HMG-CoA reductase inhibitors and method App 20020061901 - Robl, Jeffrey A. ; et al.	2002-05-23
Method for treating atherosclerosis employing an aP2 inhibitor and combination App 20020035064 - Robl, Jeffrey A. ; et al.	2002-03-21
HMG-CoA reductase inhibitors and method App 20020028826 - Robl, Jeffrey A. ; et al.	2002-03-07
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method App 20020019411 - Robl, Jeffrey A. ; et al.	2002-02-14
HMG-CoA reductase inhibitors and method App 20020013334 - Robl, Jeffrey A. ; et al.	2002-01-31
Processes and intermediates for preparing benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP Grant 6,235,922 - Robl , et al. May 22, 2	2001-05-22
Inhibitors of microsomal triglyceride transfer protein and method Grant 5,827,875 - Dickson, Jr. , et al. October 27, 1	1998-10-27
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method Grant 5,760,246 - Biller , et al. June 2, 1	1998-06-02
Inhibitors of microsomal triglyceride transfer protein and method Grant 5,712,279 - Biller , et al. January 27, 1	1998-01-27
Azepinone compounds useful in the inhibition of ACE and NEP Grant 5,587,375 - Robl December 24, 1	1996-12-24
Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase Grant 5,552,397 - Karanewsky , et al. September 3, 1	1996-09-03
Compounds containing a fused bicycle ring and processes therefor Grant 5,508,272 - Robl April 16, 1	1996-04-16
Pyridine anchors for HMG-CoA reductase inhibitors Grant 5,506,219 - Robl April 9, 1	1996-04-09
Process for preparing highly substituted phenyls Grant 5,072,023 - Robl December 10, 1	1991-12-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.